Ascentage Pharma to Attend UBS and Jefferies Investor…

Nasdaq single-stock trading halt continues, symbol not given — reason not given (10:35 AM ET) Nasdaq kept trading halted in a single listed security (reason not given) at 10:35 AM ET. M impact | EQUITY | Nov 03, 2026, 03:52 PM UTC

S&P 500 and Nasdaq Edge Higher Ahead of Midterm Results; Apple Falls 2% US stocks rose as crude oil prices fell ahead of midterm election results. Apple shares dropped 2% after its earnings failed to impress investors. M impact | EQUITY | Nov 03, 2026, 03:38 PM UTC

Meta Platforms Reportedly Targets Up to $25 Billion Bond Sale Meta Platforms has reportedly launched an investment-grade bond sale, targeting up to $25 billion. M impact | EQUITY | Nov 03, 2026, 03:37 PM UTC

Apollo Reports $53 Billion in Third-Quarter Inflows, AUM Reaches $1.07 Trillion Apollo Global Management said demand for private credit, insurance and other alternative investments helped drive record fee-related earnings. M impact | EQUITY | Nov 03, 2026, 03:36 PM UTC

Apple CEO Says Timing of iPhone Supply-Demand Balance Is Uncertain Apple’s CEO said the company cannot predict when iPhone supply and demand will balance. M impact | EQUITY | Nov 03, 2026, 03:34 PM UTC

Argentina’s Metalfor Seeks Preventive Insolvency Proceedings The agricultural machinery manufacturer sought preventive insolvency proceedings after months of financial crisis and layoffs. M impact | EQUITY | Nov 03, 2026, 03:34 PM UTC

Ascentage Pharma to Attend UBS and Jefferies Investor Conferences

Related stories